Literature DB >> 30052720

Tumor-Infiltrating Lymphocytes in Breast Cancer: Evaluating Interobserver Variability, Heterogeneity, and Fidelity of Scoring Core Biopsies.

Thaer Khoury1, Xuan Peng2, Li Yan2, Dan Wang2, Vidya Nagrale1.   

Abstract

OBJECTIVES: The aims were to evaluate breast cancer (BC) tumor-infiltrating lymphocytes (TILs) interobserver variability, heterogeneity, and the fidelity of scoring TILs in core needle biopsy (CNB).
METHODS: Matching CNB and two full-face sections (FFSs) of BC cases (n = 100) were independently reviewed by two pathologists. Percentage of stromal lymphocytes (TIL-str) and intratumoral lymphocytes (iTu-Ly) were recorded.
RESULTS: The weighted κ values for the degree of agreement between both raters were 0.53 to 0.71. However, there was a slight improvement in the interobserver variability for TIL-str and slight decline in iTu-Ly when ER+/HER2- cases were excluded. The intraclass correlation coefficient for FFS1 vs FFS2 was 0.91 for TIL-str and 0.96 for iTu-Ly. Spearman correlation coefficient for CNB vs FFS1/FFS2 was 0.81 for TIL-str and 0.79 for iTu-Ly.
CONCLUSIONS: We conclude that the agreement in TILs scoring between the raters is acceptable. Caution should be practiced when scoring iTu-Ly in CNBs.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30052720     DOI: 10.1093/ajcp/aqy069

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer.

Authors:  Iris Nederlof; Davide De Bortoli; Yacine Bareche; Bastien Nguyen; Michiel de Maaker; Gerrit K J Hooijer; Laurence Buisseret; Marleen Kok; Marcel Smid; Gert G G M Van den Eynden; Arie B Brinkman; Jan Hudecek; Jan Koster; Christos Sotiriou; Denis Larsimont; John W M Martens; Marc J van de Vijver; Hugo M Horlings; Roberto Salgado; Elia Biganzoli; Christine Desmedt
Journal:  Breast Cancer Res       Date:  2019-12-26       Impact factor: 6.466

2.  CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas.

Authors:  Depei Li; Wanming Hu; Xiaoping Lin; Ji Zhang; Zhenqiang He; Sheng Zhong; Xia Wen; Peiyu Zhang; Xiaobing Jiang; Hao Duan; Chengcheng Guo; Jian Wang; Jing Zeng; Zhongping Chen; Yonggao Mou; Ke Sai
Journal:  Front Cell Dev Biol       Date:  2021-03-19

3.  Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer.

Authors:  Sehhoon Park; Chan-Young Ock; Hyojin Kim; Sergio Pereira; Seonwook Park; Minuk Ma; Sangjoon Choi; Seokhwi Kim; Seunghwan Shin; Brian Jaehong Aum; Kyunghyun Paeng; Donggeun Yoo; Hongui Cha; Sunyoung Park; Koung Jin Suh; Hyun Ae Jung; Se Hyun Kim; Yu Jung Kim; Jong-Mu Sun; Jin-Haeng Chung; Jin Seok Ahn; Myung-Ju Ahn; Jong Seok Lee; Keunchil Park; Sang Yong Song; Yung-Jue Bang; Yoon-La Choi; Tony S Mok; Se-Hoon Lee
Journal:  J Clin Oncol       Date:  2022-03-10       Impact factor: 50.717

4.  Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study.

Authors:  Serdar Altinay; Laurent Arnould; Maschenka Balkenhol; Glenn Broeckx; Octavio Burguès; Cecile Colpaert; Franceska Dedeurwaerdere; Benjamin Dessauvagie; Valérie Duwel; Giuseppe Floris; Stephen Fox; Clara Gerosa; Delfyne Hastir; Shabnam Jaffer; Eline Kurpershoek; Magali Lacroix-Triki; Andoni Laka; Kathleen Lambein; Gaëtan Marie MacGrogan; Caterina Marchiò; Maria-Dolores Martin Martinez; Sharon Nofech-Mozes; Dieter Peeters; Alberto Ravarino; Emily Reisenbichler; Erika Resetkova; Souzan Sanati; Anne-Marie Schelfhout; Vera Schelfhout; Abeer Shaaban; Renata Sinke; Claudia M Stanciu-Pop; Carolien H M van Deurzen; Koen K Van de Vijver; Anne-Sophie Van Rompuy; Anne Vincent-Salomon; Hannah Y Wen; Serena Wong; Mieke R Van Bockstal; Aline François; Caroline Bouzin; Christine Galant
Journal:  Mod Pathol       Date:  2021-07-03       Impact factor: 7.842

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.